| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| Ab183336-100μg |
100μg |
现货  |
| |
| Ab183336-1mg |
1mg |
现货 |
| |
| Ab183336-5mg |
5mg |
现货 |
| |
| Ab183336-10mg |
10mg |
期货 |
|
| 产品名称 | Telisotuzumab vedotin (anti-c-Met), 微管蛋白抑制剂 |
|---|---|
| 别名 | 特立妥珠单抗 |
| 英文别名 | AUTS9 antibody | c met antibody | D249 antibody | Hepatocyte growth factor receptor antibody | HGF antibody | HGF receptor antibody | HGF/SF receptor antibody | HGFR antibody | MET antibody | Met proto oncogene antibody | Met proto oncogene tyrosine kinas |
| 规格或纯度 | 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥90%(SDS-PAGE&SEC-HPLC), 见COA |
| 宿主种属 | 人(Human) |
| 特异性 | MET |
| 种属反应性 | 人(Human) |
| 偶联 | MC-VC-PAB-MMAE |
| 作用类型 | 抑制剂 |
| 作用机制 | 微管蛋白抑制剂 |
| 克隆类型 | 重组抗体 |
|---|---|
| Format | Whole IgG |
| 亚型 | Human IgG1 |
| 轻链亚型 | kappa |
| SDS-PAGE | 151.36 kDa |
| 纯化方法 | Protein A purified |
| 纯度 | Purity>90% (SDS-PAGE&SEC) |
| 物理外观 | Liquid |
| 储存缓冲液 | Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, pH5.0. |
| 防腐剂 | No |
| 浓度 | 见COA |
| 储存温度 | -80℃储存,避免反复冻融 |
| 运输条件 | 超低温冰袋运输 |
| 稳定性与储存 | 在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。 |
| CAS编号和信息 | 1714088-51-3 |
| 分子类型 | 抗体偶联药物 |
Telisotuzumab vedotin (anti-c-Met) (Ab183336) - Flow Cytometry
Flow Cytometry analysis of Hela cells labelling c-Met (red) with Telisotuzumab vedotin (anti-c-Met) (Ab183336). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Telisotuzumab vedotin (anti-c-Met) (Ab183336) - Flow Cytometry
Flow Cytometry analysis of A549 cells labelling c-Met (red) with Telisotuzumab vedotin (anti-c-Met) (Ab183336). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Telisotuzumab vedotin (anti-c-Met) (Ab183336) - ELISA
Immobilized Human HGFR/c-MET protein (rp169642) at 1.0 μg/mL can bind Telisotuzumab vedotin (anti-c-Met) (Ab183336) with the EC50 of 298.4 ng/mL.
Telisotuzumab vedotin (anti-c-Met) (Ab183336) - SEC
The purity of Telisotuzumab vedotin (anti-c-Met) (Ab183336) is more than 95% verified by HPLC.
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
通过匹配包装上的批号来查找并下载产品的 COA，每批产品都进行了严格的验证，您可放心使用！
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
 ZJ24F0505688 |
分析证书 | 24-05-16 | Ab183336 |
| ZJ24F0505691 |
分析证书 | 24-05-16 | Ab183336 |
| ZJ24F0505689 |
分析证书 | 24-05-16 | Ab183336 |
首页
400-620-6333
